NAVB Analysis

Navidea Biopharmaceuticals, Inc.
Stock Exchange: AMEX
Sector: healthcare
0.841
Last session price
0.841
Price now
Currency: USD
Reporting currency: USD
ISIN: US63937X2027
INN:
.

NAVB financial statements

* Numbers in thousands
Capitalization * 23 604
EV * 59 259
Number of shares * 28 066
EPS -0,38
Revenue * 915
Net income * -10 722
Operating profit * -10 711
Total liabilities * 5 711
Net debt * -1 334
Total assets * 7 758
Equity * 1 316
Cash and investments * 2 670
.

NAVB valuation

P/E -2,20
P/B 17,94
P/S 25,80
E/P -45
P/FCF -2,75
.

NAVB profitability

ROE -815%
ROA% -150%
ROIC% -352%